Laura Ann Navalta
About Laura Ann Navalta
Laura Navalta's Professional Title
Laura Navalta holds the position of Senior Vice President of Clinical Operations. In this role, she leads the clinical trials team at Cidara Therapeutics. Her responsibilities include ensuring the successful execution of clinical studies and overseeing the comprehensive aspects of clinical operations.
Laura Navalta's Education and Expertise
Laura Navalta received her B.A. in Developmental Psychology from the University of Southern California. With over 30 years of extensive experience in the clinical operations arena, she has developed a deep understanding of clinical project management, regulatory requirements, and global clinical study conduct.
Laura Navalta's Career Background
Laura Navalta's career includes significant roles in various pharmaceutical and biotechnology companies. She served as Chief Operating Officer at C3 Jian Therapeutics and Novalar Pharmaceuticals, where she led clinical, regulatory, and project management functions. At Vical, Inc., she was the Executive Director of Clinical Operations, overseeing all clinical trials in oncology and infectious disease programs. At Baxter Healthcare Corporation, she was the Senior Director of Global Clinical Operations, BioScience Division, managing global clinical studies related to coagulation disorders, biosurgery, and critical care areas.
Laura Navalta's Roles and Responsibilities
Throughout her career, Laura Navalta has held several senior advisory roles across multiple therapeutic areas and phases of drug development. Her expertise covers the planning and execution of clinical trials, regulatory compliance, and project management. At Cidara Therapeutics, she leads the clinical operations team, focusing on the efficient and accurate management of clinical trials.